MedPath

TO study efficacy of non cultured, non trypsinised epidermal cell transplantation(a type of skin grafting procedure) in stable(non progressive, resitant to medical treatment) vitiligo.

Phase 2/3
Not yet recruiting
Conditions
Vitiligo,
Registration Number
CTRI/2020/11/028973
Lead Sponsor
Department of Dermatology Venerology and Leprosy
Brief Summary

prospective study is aimed at studying the clinical efficacy of non-cultured non-trypsinised epidermal cell grafting technique for stable vitiligo patient

The degree of repigmentation will be observed at 4 weeks,8 weeks and 16 weeks  and graded  by comparison of successive photographs of the patches

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
21
Inclusion Criteria

12 years and above stable vitiligo.

Exclusion Criteria

1.Presence of koebner’s phenomenon 2.Refusal to consent 3.Pregnancy or lactation 4.Patients with unrealistic expectations from treatment 5.Patients with a tendency for keloid formation 6.Active cutaneous infection 7.History suggestive of autoimmune disorders 8.Patient with any hematological or coagulation disorders or on anticoagulation therapy Patients who are immunosuppressed.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of Repigmentation16 Week
Secondary Outcome Measures
NameTimeMethod
Degree of RepigmentationComplications at the site of surgery

Trial Locations

Locations (1)

DR. Rajender Prasad Govt. Medical COLLEGE

🇮🇳

Kangra, HIMACHAL PRADESH, India

DR. Rajender Prasad Govt. Medical COLLEGE
🇮🇳Kangra, HIMACHAL PRADESH, India
Dr Sheenam Hooda
Principal investigator
8607201825
sheenamhooda2012@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.